Terms: = Liver cancer AND NDRG1, NDR1, 10397, ENSG00000104419, Q92597, RIT42, CMT4D, TARG1, HMSNL, GC4, RTP, TDD5, PROXY1, NMSL, CAP43 AND Treatment
19 results:
1. Unleashing the potential of gene signatures as prognostic and predictive tools: A step closer to personalized medicine in hepatocellular carcinoma (HCC).
Pourbagheri-Sigaroodi A; Fallah F; Bashash D; Karimi A
Cell Biochem Funct; 2024 Jan; 42(1):e3913. PubMed ID: 38269520
[TBL] [Abstract] [Full Text] [Related]
2. Integrative analysis of disulfidptosis and immune microenvironment in hepatocellular carcinoma: a putative model and immunotherapeutic strategies.
Yang T; Liu J; Liu F; Lei J; Chen S; Ma Z; Ke P; Yang Q; Wen J; He Y; Duan J; Zeng X
Front Immunol; 2023; 14():1294677. PubMed ID: 38235128
[TBL] [Abstract] [Full Text] [Related]
3. Seven oxidative stress-related genes predict the prognosis of hepatocellular carcinoma.
Miao C; He X; Chen G; Kahlert UD; Yao C; Shi W; Su D; Hu L; Zhang Z
Aging (Albany NY); 2023 Dec; 15(24):15050-15063. PubMed ID: 38097352
[TBL] [Abstract] [Full Text] [Related]
4. LINC02561 promotes metastasis in HCC via HIF1-α/ndrg1/UPF1 axis.
Li SN; Li MX; Guo WW; Zhang LR; Ding YH; Wu XJ
Gene; 2024 Feb; 896():148033. PubMed ID: 38013127
[TBL] [Abstract] [Full Text] [Related]
5. The integration of machine learning and multi-omics analysis provides a powerful approach to screen aging-related genes and predict prognosis and immunotherapy efficacy in hepatocellular carcinoma.
Shen J; Gao H; Li B; Huang Y; Shi Y
Aging (Albany NY); 2023 Jul; 15(14):6848-6864. PubMed ID: 37517087
[TBL] [Abstract] [Full Text] [Related]
6. Construction and validation of 3-genes hypoxia-related prognostic signature to predict the prognosis and therapeutic response of hepatocellular carcinoma patients.
Liu Y; Shen B; Huang T; Wang J; Jiang J
PLoS One; 2023; 18(7):e0288013. PubMed ID: 37406019
[TBL] [Abstract] [Full Text] [Related]
7. Tolerability of Eribulin and correlation between polymorphisms and neuropathy in an unselected population of female patients with metastatic breast cancer: results of the multicenter, single arm, phase IV PAINTER study.
La Verde N; Damia G; Garrone O; Santini D; Fabi A; Ciccarese M; Generali DG; Nunzi M; Poletto E; Ferraris E; Cretella E; Scandurra G; Meattini I; Bertolini AS; Cavanna L; Collovà E; Romagnoli E; Rulli E; Legramandi L; Guffanti F; Bramati A; Moretti A; Cassano A; Vici P; Torri V; Farina G;
Breast Cancer Res; 2022 Oct; 24(1):71. PubMed ID: 36307826
[TBL] [Abstract] [Full Text] [Related]
8. Claudin-2 promotes colorectal cancer growth and metastasis by suppressing ndrg1 transcription.
Wei M; Zhang Y; Yang X; Ma P; Li Y; Wu Y; Chen X; Deng X; Yang T; Mao X; Qiu L; Meng W; Zhang B; Wang Z; Han J
Clin Transl Med; 2021 Dec; 11(12):e667. PubMed ID: 34965023
[TBL] [Abstract] [Full Text] [Related]
9. FOXQ1/ndrg1 axis exacerbates hepatocellular carcinoma initiation via enhancing crosstalk between fibroblasts and tumor cells.
Luo Q; Wang CQ; Yang LY; Gao XM; Sun HT; Zhang Y; Zhang KL; Zhu Y; Zheng Y; Sheng YY; Lu L; Jia HL; Yu WQ; Liu J; Dong QZ; Qin LX
Cancer Lett; 2018 Mar; 417():21-34. PubMed ID: 29248714
[TBL] [Abstract] [Full Text] [Related]
10. Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker.
Chiang KC; Yeh TS; Wu RC; Pang JS; Cheng CT; Wang SY; Juang HH; Yeh CN
Sci Rep; 2016 Oct; 6():36138. PubMed ID: 27782193
[TBL] [Abstract] [Full Text] [Related]
11. Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells.
Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH
Biomed Pharmacother; 2016 Oct; 83():607-616. PubMed ID: 27459117
[TBL] [Abstract] [Full Text] [Related]
12. Antimetastatic effect of fluvastatin on breast and hepatocellular carcinoma cells in relation to SGK1 and ndrg1 genes.
Salis O; Okuyucu A; Bedir A; Gör U; Kulcu C; Yenen E; Kılıç N
Tumour Biol; 2016 Mar; 37(3):3017-24. PubMed ID: 26419593
[TBL] [Abstract] [Full Text] [Related]
13. ndrg1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3β and Nur77 to prevent β-catenin degradation.
Lu WJ; Chua MS; Wei W; So SK
Oncotarget; 2015 Oct; 6(30):29847-59. PubMed ID: 26359353
[TBL] [Abstract] [Full Text] [Related]
14. Comprehensive MRI simulation methodology using a dedicated MRI scanner in radiation oncology for external beam radiation treatment planning.
Paulson ES; Erickson B; Schultz C; Allen Li X
Med Phys; 2015 Jan; 42(1):28-39. PubMed ID: 25563245
[TBL] [Abstract] [Full Text] [Related]
15. Asiatic acid promotes p21(WAF1/CIP1) protein stability through attenuation of ndr1/2 dependent phosphorylation of p21(WAF1/ CIP1) in HepG2 human hepatoma cells.
Chen JY; Chen JY; Xu QW; Xu H; Huang ZH
Asian Pac J Cancer Prev; 2014; 15(2):963-7. PubMed ID: 24568526
[TBL] [Abstract] [Full Text] [Related]
16. Hypoxia and retinoic acid-inducible ndrg1 expression is responsible for doxorubicin and retinoic acid resistance in hepatocellular carcinoma cells.
Jung EU; Yoon JH; Lee YJ; Lee JH; Kim BH; Yu SJ; Myung SJ; Kim YJ; Lee HS
Cancer Lett; 2010 Dec; 298(1):9-15. PubMed ID: 20573444
[TBL] [Abstract] [Full Text] [Related]
17. The development and testing of a digital PET phantom for the evaluation of tumor volume segmentation techniques.
Aristophanous M; Penney BC; Pelizzari CA
Med Phys; 2008 Jul; 35(7):3331-42. PubMed ID: 18697557
[TBL] [Abstract] [Full Text] [Related]
18. Three-dimensional treatment planning using electrocardiographically gated multi-detector row CT.
Yamada K; Soejima T; Minami T; Yoden E; Watanabe Y; Takenaka D; Imai M; Okayama T; Fujii M; Sugimura K
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):235-9. PubMed ID: 12694844
[TBL] [Abstract] [Full Text] [Related]
19. Three-dimensional treatment planning and conformal radiation therapy: preliminary evaluation.
Perez CA; Purdy JA; Harms W; Gerber R; Graham MV; Matthews JW; Bosch W; Drzymala R; Emami B; Fox S
Radiother Oncol; 1995 Jul; 36(1):32-43. PubMed ID: 8525023
[TBL] [Abstract] [Full Text] [Related]
